Ironwood And Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
Oct 13th 2008Drug InformationIrritable-Bowel Syndrome
Ironwood Pharmaceuticals (formerly Microbia) announced presentation of data from a pair of preclinical studies delineating the role that cyclic guanosine monophosphate (cGMP) plays in alleviating intestinal pain. These studies demonstrate that cGMP inhibits intestinal pain in a preclinical model of intestinal hyperalgesia and desensitizes colonic afferent nerves in a similar model of experimental colitis.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
